 |
2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-C]pyridine-3,6(2H,5H)-dione |
|---|---|
| Trade Name | |
| Orphan Indication | Idiopathic pulmonary fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2010-09-21 00:00:00 |
| Sponsor | GenKyoTex S.A.;14 Chemin des Aulx;Geneva |
